Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Curtis Gale Oltmans currently holds 10,252 shares of Fulcrum Therapeutics, Inc. (FULC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Curtis Gale Oltmans has been a net seller of FULC stock. They have purchased $9.8K and sold $1.5M worth of shares.
Curtis Gale Oltmans's most recent insider trade was on Dec 15, 2025, when they sold 3,452 shares at $12.92 per share.
Curtis Gale Oltmans serves as Executive at Fulcrum Therapeutics, Inc. (FULC). They have executed 17 insider transactions totaling $1.5M over their tenure at the company.
Curtis Gale Oltmans holds the position of Executive at Fulcrum Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Curtis Gale Oltmans has shown a selling trading pattern, with $9.8K in total purchases and $1.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Curtis Gale Oltmans was on Feb 5, 2019, when they sold $800.0K worth of ARRY shares. This transaction involved 40,000 shares at $20.00 per share.
Curtis Gale Oltmans currently owns 10,252 shares of Fulcrum Therapeutics, Inc. (FULC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Curtis Gale Oltmans's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Curtis Gale Oltmans has 17 Form 4 filings on record as an insider at Fulcrum Therapeutics, Inc..
Set alerts for Curtis Gale Oltmans and 40,000+ other insiders.